HER2 POSITIVE SALIVARY GLAND CANCER

HER2 POSITIVE SALIVARY GLAND CANCER was reported 14 times

HER2 POSITIVE SALIVARY GLAND CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 HER2/neu Receptor Antagonist [EPC] 14 0.0002
1 Microtubule Inhibitor [EPC] 13 0.0001
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 4 0.0000